Clinician Trends in Prescribing Direct Oral Anticoagulants for US Medicare Beneficiaries
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinician Trends in Prescribing Direct Oral Anticoagulants for US Medicare Beneficiaries
Authors
Keywords
-
Journal
JAMA Network Open
Volume 4, Issue 12, Pages e2137288
Publisher
American Medical Association (AMA)
Online
2021-12-07
DOI
10.1001/jamanetworkopen.2021.37288
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Direct Oral Anticoagulant Use: A Practical Guide to Common Clinical Challenges
- (2020) Ashley Chen et al. Journal of the American Heart Association
- American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism
- (2020) Thomas L. Ortel et al. Blood Advances
- 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
- (2019) Craig T. January et al. CIRCULATION
- Meta-analysis of Direct-Acting Oral Anticoagulants Compared to Warfarin in Patients >75 Years of Age
- (2019) Aaqib H. Malik et al. AMERICAN JOURNAL OF CARDIOLOGY
- Evolution of Medicare Formulary Coverage Changes for Antithrombotic Therapies After Guideline Updates
- (2019) Elias J. Dayoub et al. CIRCULATION
- Oral Anticoagulation in Patients With Liver Disease
- (2018) Arman Qamar et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Medicare part D prescribing for direct oral anticoagulants in the United States: Cost, use and the “rubber effect”
- (2018) Panayiotis D. Ziakas et al. PLoS One
- Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis
- (2017) José A López-López et al. BMJ-British Medical Journal
- Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis
- (2017) José A López-López et al. BMJ-British Medical Journal
- Effects of Non–Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: A Systematic Review and Meta‐Analysis
- (2017) Kuo‐Li Pan et al. Journal of the American Heart Association
- Prevalence, Characteristics, and Outcomes of Valvular Heart Disease in Patients With Atrial Fibrillation: Insights From the ORBIT‐AF (Outcomes Registry for Better Informed Treatment for Atrial Fibrillation)
- (2017) Kevin L. Thomas et al. Journal of the American Heart Association
- Fitting Linear Mixed-Effects Models Usinglme4
- (2015) Douglas Bates et al. Journal of Statistical Software
- 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
- (2014) Craig T. January et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- New Oral Anticoagulants in Elderly Adults: Evidence from a Meta-Analysis of Randomized Trials
- (2014) Partha Sardar et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Evaluation of medical costs associated with use of new oral anticoagulants compared with standard therapy among venous thromboembolism patients
- (2014) Alpesh Amin et al. JOURNAL OF MEDICAL ECONOMICS
- Treatment of Acute Venous Thromboembolism With Dabigatran or Warfarin and Pooled Analysis
- (2013) Sam Schulman et al. CIRCULATION
- Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
- (2013) Christian T Ruff et al. LANCET
- Edoxaban versus Warfarin in Patients with Atrial Fibrillation
- (2013) Robert P. Giugliano et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oral Apixaban for the Treatment of Acute Venous Thromboembolism
- (2013) Giancarlo Agnelli et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- Apixaban versus Warfarin in Patients with Atrial Fibrillation
- (2011) Christopher B. Granger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
- (2011) Manesh R. Patel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oral Rivaroxaban for Symptomatic Venous Thromboembolism
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Dabigatran versus Warfarin in Patients with Atrial Fibrillation
- (2009) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
- (2009) Sam Schulman et al. NEW ENGLAND JOURNAL OF MEDICINE
- The story of the discovery of heparin and warfarin
- (2008) Douglas Wardrop et al. BRITISH JOURNAL OF HAEMATOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started